These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 22736085)

  • 41. Treat-to-target in rheumatoid arthritis: a real-world study of the application and impact of treat-to-target within the wider context of patient management, patient centricity and advanced therapy use in Europe.
    Taylor PC; Fautrel B; Piette Y; Romero-Yuste S; Broen J; Welcker M; Howell O; Rottier E; Zignani M; Van Beneden K; Caporali R; Alten R
    RMD Open; 2022 Dec; 8(2):. PubMed ID: 36549856
    [TBL] [Abstract][Full Text] [Related]  

  • 42. American College of Rheumatology/EULAR remission criteria for rheumatoid arthritis: 2022 revision.
    Studenic P; Aletaha D; de Wit M; Stamm TA; Alasti F; Lacaille D; Smolen JS; Felson DT
    Ann Rheum Dis; 2023 Jan; 82(1):74-80. PubMed ID: 36280238
    [TBL] [Abstract][Full Text] [Related]  

  • 43. American College of Rheumatology/EULAR Remission Criteria for Rheumatoid Arthritis: 2022 Revision.
    Studenic P; Aletaha D; de Wit M; Stamm TA; Alasti F; Lacaille D; Smolen JS; Felson DT
    Arthritis Rheumatol; 2023 Jan; 75(1):15-22. PubMed ID: 36274193
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Overtreatment in rheumatoid arthritis: are there reasons for concern?
    Ferreira RJO; Gossec L; da Silva JAP
    RMD Open; 2022 Sep; 8(2):. PubMed ID: 36180100
    [No Abstract]   [Full Text] [Related]  

  • 45. Remission or Not Remission, That's the Question: Shedding Light on Remission and the Impact of Objective and Subjective Measures Reflecting Disease Activity in Rheumatoid Arthritis.
    Brkic A; Łosińska K; Pripp AH; Korkosz M; Haugeberg G
    Rheumatol Ther; 2022 Dec; 9(6):1531-1547. PubMed ID: 36129667
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Validity and risk of adopting PGA ≤ 2 as a remission criteria of Boolean in clinical practice in patient with rheumatoid arthritis.
    Yoshii I; Chijiwa T; Sawada N
    Sci Rep; 2022 Feb; 12(1):2978. PubMed ID: 35194126
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Inflammation and biologic therapy in patients with rheumatoid arthritis achieving versus not achieving ACR/EULAR Boolean remission in a treat-to-target study.
    Paulshus Sundlisæter N; Sundin U; Aga AB; Sexton J; Hammer HB; Uhlig T; Kvien TK; Haavardsholm EA; Lillegraven S
    RMD Open; 2022 Jan; 8(1):. PubMed ID: 35091463
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Reply.
    Felson D; LaValley M; Lacaille D; Aletaha D
    ACR Open Rheumatol; 2022 Mar; 4(3):269-270. PubMed ID: 35089654
    [No Abstract]   [Full Text] [Related]  

  • 49. Patient-Reported Outcomes in Systemic Lupus Erythematosus. Can Lupus Patients Take the Driver's Seat in Their Disease Monitoring?
    Parodis I; Studenic P
    J Clin Med; 2022 Jan; 11(2):. PubMed ID: 35054036
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Development of quality standards for patients with rheumatoid arthritis for use in Germany].
    Kiltz U; Buschhorn-Milberger V; Albrecht K; Lakomek HJ; Lorenz HM; Rudwaleit M; Schneider M; Schulze-Koops H; Aringer M; Hasenbring MI; Herzer P; von Hinüber U; Krüger K; Lauterbach A; Manger B; Oltman R; Schuch F; Schmale-Grede R; Späthling-Mestekemper S; Zinke S; Braun J
    Z Rheumatol; 2022 Nov; 81(9):744-759. PubMed ID: 34652486
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparison of the effects of baricitinib and tocilizumab on disease activity in patients with rheumatoid arthritis: a propensity score matching analysis.
    Asai S; Takahashi N; Kobayakawa T; Kaneko A; Watanabe T; Kato T; Nishiume T; Ishikawa H; Yoshioka Y; Kanayama Y; Watanabe T; Hirano Y; Hanabayashi M; Yabe Y; Yokota Y; Suzuki M; Terabe K; Ishiguro N; Imagama S; Kojima T
    Clin Rheumatol; 2021 Aug; 40(8):3143-3151. PubMed ID: 34136969
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Limiting factors to Boolean remission differ between autoantibody-positive and -negative patients in early rheumatoid arthritis.
    Bugatti S; De Stefano L; Manzo A; Sakellariou G; Xoxi B; Montecucco C
    Ther Adv Musculoskelet Dis; 2021; 13():1759720X211011826. PubMed ID: 34093745
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Persistent inflammatory and non-inflammatory mechanisms in refractory rheumatoid arthritis.
    Buch MH; Eyre S; McGonagle D
    Nat Rev Rheumatol; 2021 Jan; 17(1):17-33. PubMed ID: 33293696
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Patient Perception of Depressive Symptoms in Rheumatic Diseases: A Cross-sectional Survey.
    Ingegnoli F; Schioppo T; Ubiali T; Ostuzzi S; Bollati V; Buoli M; Caporali R
    J Clin Rheumatol; 2022 Jan; 28(1):e18-e22. PubMed ID: 32925449
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Testing different thresholds for patient global assessment in defining remission for rheumatoid arthritis: are the current ACR/EULAR Boolean criteria optimal?
    Studenic P; Felson D; de Wit M; Alasti F; Stamm TA; Smolen JS; Aletaha D
    Ann Rheum Dis; 2020 Apr; 79(4):445-452. PubMed ID: 32024651
    [TBL] [Abstract][Full Text] [Related]  

  • 56. What Does the Patient Global Health Assessment in Rheumatoid Arthritis Really Tell Us? Contribution of Specific Dimensions of Health-Related Quality of Life.
    Craig ET; Perin J; Zeger S; Curtis JR; Bykerk VP; Bingham CO; Bartlett SJ
    Arthritis Care Res (Hoboken); 2020 Nov; 72(11):1571-1578. PubMed ID: 31549772
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prevalence of feet and ankle arthritis and their impact on clinical indices in patients with rheumatoid arthritis: a cross-sectional study.
    Lee SW; Kim SY; Chang SH
    BMC Musculoskelet Disord; 2019 Sep; 20(1):420. PubMed ID: 31506089
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Predicting drug-free remission in rheumatoid arthritis: A prospective interventional cohort study.
    Baker KF; Skelton AJ; Lendrem DW; Scadeng A; Thompson B; Pratt AG; Isaacs JD
    J Autoimmun; 2019 Dec; 105():102298. PubMed ID: 31280933
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Predictors and the optimal duration of sustained remission in rheumatoid arthritis.
    Yilmaz-Oner S; Gazel U; Can M; Atagunduz P; Direskeneli H; Inanc N
    Clin Rheumatol; 2019 Nov; 38(11):3033-3039. PubMed ID: 31270696
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical deep remission and related factors in a large cohort of patients with rheumatoid arthritis.
    Liu JJ; Li R; Gan YZ; Zhang RJ; Li J; Cai YM; Zhao JX; Liao H; Xu J; Shi LJ; Li J; Li SG; Sun XL; He J; Liu X; Ye H; Li ZG
    Chin Med J (Engl); 2019 May; 132(9):1009-1014. PubMed ID: 30946065
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.